Histamine type 1-receptor activation by low dose of histamine undermines human glomerular slit diaphragm integrity. by Veglia,  Eleonora et al.
Durham Research Online
Deposited in DRO:
07 November 2017
Version of attached ﬁle:
Published Version
Peer-review status of attached ﬁle:
Peer-reviewed
Citation for published item:
Veglia, Eleonora and Pini, Alessandro and Moggio, Aldo and Grange, Cristina and Premoselli, Federica and
Miglio, Gianluca and Tiligada, Katerina and Fantozzi, Roberto and Chazot, Paul L. and Rosa, Arianna
Carolina (2016) 'Histamine type 1-receptor activation by low dose of histamine undermines human glomerular
slit diaphragm integrity.', Pharmacological research., 114 . pp. 27-38.
Further information on publisher's website:
https://doi.org/10.1016/j.phrs.2016.10.011
Publisher's copyright statement:
c© 2017 This manuscript version is made available under the CC-BY-NC-ND 4.0 license
http://creativecommons.org/licenses/by-nc-nd/4.0/
Additional information:
Use policy
The full-text may be used and/or reproduced, and given to third parties in any format or medium, without prior permission or charge, for
personal research or study, educational, or not-for-proﬁt purposes provided that:
• a full bibliographic reference is made to the original source
• a link is made to the metadata record in DRO
• the full-text is not changed in any way
The full-text must not be sold in any format or medium without the formal permission of the copyright holders.
Please consult the full DRO policy for further details.
Durham University Library, Stockton Road, Durham DH1 3LY, United Kingdom
Tel : +44 (0)191 334 3042 | Fax : +44 (0)191 334 2971
http://dro.dur.ac.uk
 1 
Histamine Type 1-Receptor activation by low dose of histamine undermines human 1 
Glomerular Slit Diaphragm Integrity 2 
Eleonora Vegliaa#, Alessandro Pinib#*, Aldo Moggioa1, Cristina Grangec, Federica Premosellid, 3 
Gianluca Miglioa, Katerina Tiligadae Roberto Fantozzia, Paul L. Chazotf, Arianna Carolina Rosaa,f 4 
 5 
#Authors contributed equally to this work  6 
aDepartment of Scienza e Tecnologia del Farmaco, University of Turin, Via P. Giuria 9 - 10125, 7 
Turin, Italy, eveglia@unito.it, aldomoggio@gmail.com, rfantozzi@unito.it, acrosa@unito.it; 8 
bDepartment of Clinical and Experimental Medicine, University of Florence, Viale Pieraccini 6 - 9 
50139, Florence, Italy, apini@unito.it; cDepartment of Scienze Mediche, University of Turin, C.So 10 
Dogliotti 14 - 10126 Turin, Italy, cgrange@unito.it; dDepartment of Neuroscience "Rita Levi 11 
Montalcini", University of Turin, Via Cherasco 15, 10126 Turin, Italy, fpremoselli@unito.it; 12 
eDepartment of Pharmacology, Medical School, University of Athens, M. Asias 75 GR-115 27 13 
Athens, Greece, aityliga@med.uoa.gr; fSchool of Biological and Biomedical Science, Durham 14 
University, Durham DH13LE, UK, paul.chazot@durham.ac.uk 15 
 16 
*Corresponding author: Alessandro Pini, PhD 17 
Dipartimento di Medicina Sperimentale e Clinica Sezione di Anatomia e 18 
Istologia Università degli Studi di Firenze,  19 
Viale Pieraccini 6, 50139, Florence, Italy 20 
Phone: +390552758155 21 
e-mail: alessandro.pini@unifi.it 22 
1 Present affiliation: Integrated Cardio Metabolic Centre, Department of Medicine, Huddinge 23 
(MedH), H7, Karolinska Institute, SE-171 77 Stockholm, Sweden 24 
*Manuscript
Click here to view linked References
 2 
Abstract 25 
Histamine has been reported to decrease the ultrafiltration coefficient, which inversely correlates 26 
with glomerular permselectivity, however the mechanism(s) underling this effect have never been 27 
investigated. This study aimed to assess whether histamine could exert a direct detrimental effect on 28 
podocyte permeability and the possible involvement of two key proteins for the glomerular slit 29 
diaphragm (SD) integrity, zonula occludens-1 (ZO-1) and P-cadherin.  30 
The effect of histamine (100 pM-1000 nM) on coloured podocytes junctional integrity was 31 
evaluated functionally by a transwell assay of monolayer permeability and morphologically by 32 
electron microscopy. Histamine receptor (H1-4R) presence was evaluated at both mRNA (RT-PCR) 33 
and protein (immunofluorescence) levels. The Kd and Bmax values for [3H]mepyramine were 34 
detemined by saturation binding analysis; IP1 and cAMP production evoked by histamine were 35 
measured by TR-FRET. ZO-1, P-cadherin and vimentin expression was assessed by qRT-PCR and 36 
quantitative immunoblotting.  37 
Histamine elicited a time- and sigmoidal dose-dependent (maximum effect at 8 h, 10 nM) increase 38 
in podocyte paracellular permeability widening the paracellular spaces. Only H1R was 39 
predominantly localised to the podocyte membrane. Consistently, histamine elicited a sigmoidal 40 
dose-dependent increase in IP1, but not in cAMP. Histamine exposure evoked a concentration-41 
dependent reduction in both ZO-1 and P-cadherin and a parallel induction of vimentin mRNA 42 
expression with a maximum effect after 6 h, and protein expression with a maximum effect after 8h. 43 
These effects were prevented by the selective H1R antagonist chlorpheniramine.  44 
In conclusion, our data demonstrate that histamine, via the H1R, modifies SD morphological and 45 
functional integrity, in part, by decreasing the expression of ZO-1 and P-cadherin. 46 
 47 
Keywords: histamine, podocytes, paracellular permeability, histamine receptors, junction integrity. 48 
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Abbreviations cAMP, cyclic adenosine monophosphate; CDH3, cadherin 3, type 1, P-cadherin 49 
gene; ER, endoplasmic reticulum; FITC, fluorescein; GADPH, glyceraldehyde 3-phosphate 50 
dehydrogenase gene; GBM, glomerular basement membrane; H1-4R, histamine receptor 1-4 subtypes; 51 
Kf, ultrafiltration coefficient; IP1, inositol monophosphate; IP3, inositol 1,4,5-trisphosphate; PAN, 52 
puromycin aminonucleoside; qRT-PCR, quantitative real-time PCR; SD, slit diaphragm; TBP, 53 
TATA-binding protein; TJP1, tight junction protein 1 gene; TR-FRET, Time-Resolved 54 
Fluorescence Resonance Energy Transfer; VIM vimentin gene; ZO, Zonula Occludens 55 
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1 Introduction 57 
Histamine is a pleiotropic vasoactive amine, whose pathogenic role in microvascular endothelial 58 
paracellular permeability has been extensively studied [1-7]. Most of these studies describe acute 59 
events (within seconds to minutes), resulting in a rapid transient increase in permeability, due to a 60 
rapid formation of endothelial gaps [2-7]. Moreover, histamine has been suggested to be involved in 61 
prolonged vascular leakage by reducing Zonula Occludens (ZO)-1 protein expression in cultured 62 
retinal microvascular endothelial cells within hours [8]. The work by Takeuchi K and colleagues 63 
(2001) suggested that histamine-induced paracellular permeability might be also extended to other 64 
epithelial cells. In particular, histamine was shown to significantly downregulate ZO-1 mRNA 65 
expression in cultured human nasal epithelial cells [9]. ZO-1 contributes to the functional integrity 66 
of different permeability barriers among which the glomerular filter is one [10]. Interestingly, 67 
histamine has been previously reported to decrease the ultrafiltration coefficient (Kf) [11]. Thus, our 68 
hypothesis was that histamine could modify Kf by regulating ZO-1 expression in the podocyte. 69 
Podocytes are parenchymal cells known to be highly dynamic and terminally differentiated. They 70 
interact with the glomerular basement membrane (GBM) and communicate through various 71 
signalling pathways at the slit diaphragm (SD). The glomerular SD represents the junction structure 72 
that links the interdigitating foot processes from neighbouring podocytes and consists of 73 
transmembrane-bridging proteins networking with a juxtaposed cytoplasmic platform of protein 74 
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complexes, which in turn is linked to the actin cytoskeleton [12]. Within this cytoarchitecture, ZO-1 75 
protein is located at the cytoplasmic face of the SD [13] and has been accepted to be one of its 76 
functional molecules; a disrupted interaction and distribution of ZO-1 in podocytes results in loss of 77 
SD structure and function [14-16]. Besides the transmembrane protein, P-cadherin, a podocyte 78 
specific adhesion protein [17] localised on adherens-type junctions, mediates calcium-dependent 79 
cell-cell bonds and its loss is recognised as a cause of barrier filtration integrity impairment [18]. 80 
Therefore, it is likely that glomerular injury affecting ZO-1 and/or P-cadherin results in loss of SD 81 
structure, podocyte detachment, Kf reduction and in a subsequent impairment of the filtration 82 
barrier integrity with proteinuria, progressive renal damage and eventual loss of renal function [12, 83 
19, 20].  84 
Among the histamine receptor subtypes, H1-4R, H1R and H2R were first described in mammalian 85 
glomeruli [21-23], but these studies were focused on the entire glomerulus or only on stromal cells 86 
such as mesangial cells; little is known about parenchymal cells. Indeed, the data on histamine 87 
receptors expression on renal parenchymal cells arise only from our recent observations of H1R, 88 
H2R, H3R and H4R on tubular epithelial cells [24-26]. However, no such studies have to date 89 
focused on podocytes.  90 
Thus, the present study was designed to investigate whether histamine could exert a direct 91 
detrimental effect on podocyte permeability compromising SD functional integrity, the underlying 92 
histamine receptor pharmacology, and the possible involvement of two key SD-associated proteins 93 
ZO-1 and P-cadherin.  94 
2 Materials and Methods 95 
2.1 Materials 96 
All reagents and chemicals used were from Sigma–Aldrich (St. Louis, MO) unless otherwise noted. 97 
Cell media and reagents were from Lonza group Ltd. (Allendale, NJ, USA). Hans Balanced Salt 98 
Solution was from GIBCO (Grand Island, NY). HTS Transwell inserts were from Corning Life 99 
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Sciences (Lowell, MA). RevertAid™ First Strand cDNA Synthesis Kit, GeneRuler™ 50 bp DNA 100 
Ladder, DNA Gel Loading Dye (6X), CellMask™ Orange plasma membrane stain, MagicMark™ 101 
XP Western Protein Standard and Alexa-Conjugated secondary antibodies donkey anti-Mouse IgG 102 
(A-31570), chicken anti-Goat IgG (A-21469) and goat anti-Rabbit IgG (A-11034) were from 103 
Thermo Fisher Scientific Inc. (Rockford, IL, USA). EuroTaq DNA polymerase as well as 104 
EuroGOLD Trifast™ were from Euro-clone (Milan, Italy). High Capacity cDNA Reverse 105 
Transcription Kit and Power SYBR Green PCR Master Mix were from Applied Biosystems (Foster 106 
City, CA). Sequence-specific oligonucleotide primers were purchase from Sigma-Genosys (Milan 107 
Italy). The antibodies for histamine H1R (H300, sc-20633), H2R (A20, sc-33973), calnexin (AF18, 108 
sc-23954), ZO-1 (C-19, sc-8146), P-cadherin (H-105, sc-7893), vimentin (C20, sc-7557) and 109 
UltraCruz™ Autoradiography Film were purchased from Santa Cruz Biotechnology Inc. (Dallas, 110 
TX, USA), while anti-rabbit and anti-mouse IgG HRP-linked antibodies were from Cell Signaling 111 
Technology, Inc. (Danvers, MA, USA) and the swine anti-Goat IgG antibody from Cedarlane Labs 112 
(Ontario, Canada). The LANCE® Ultra cAMP Detection Kit, the IP-One HTRF® assay kit, the 113 
[3H]mepyramine [PubChemCID 656400; kindly provided by Prof. Rob Leurs (20 Ci/mmol) VU 114 
University Amsterdam, Amsterdam] and the Whatman™GF/C Glass Fiber Filter Paper were from 115 
PerkinElmer Inc. (Waltham, MA, USA) and Cisbio Bioassays (France), respectively. Precision Plus 116 
Protein™ Dual Color Standards and BCA protein assay were from Pierce Bio-technology Inc. 117 
(Rockford, IL, USA) and PVDF membrane from Millipore (Bradford, MA, USA). Visiglo™ HRP 118 
chemiluminescent substrate kit was purchased from Amresco llc. (Solon, OH, USA).  119 
Histamine dihydrochloride (PubChem CID 5818), (+/-) chlorpheniramine maleate (PubChem CID 120 
5281068), [3H]mepyramine and difenhydramine (Pubmed CID 3100) were dissolved in dimethyl 121 
sulfoxide, and the final drug concentrations were obtained by dilution of stock solutions in the 122 
experimental buffers. The final concentration of the organic solvent was less than 0.1%, which had 123 
no effect on cell viability. 124 
2.2 Cell cultures  125 
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Immortalised human podocytes were obtained from the respective primary cells, derived from the 126 
normal portion of cortex surgically removed kidneys (n=5) for  as described previously [27], by 127 
infection with a hybrid Adeno5/SV40 virus as previously described [27-29]. The line was generated 128 
in 1997, after the authorization of the local Ethical Committee (Hospital San Giovanni Battista 129 
"Molinette", Turin, Italy). Podocytes were isolated from the healthy tissue derived from kidney 130 
samples of patients who underwent unilateral nephrectomy due to local renal carcinomas as first-131 
line treatment. To our knowledge, no other relevant pathology was diagnosed in the medical history 132 
of each patient enrolled and the derived podocytes can be reasonable assumed as healthy podocytes. 133 
Podocytes were characterised for the positive expression of nephrin, podocin, and synaptopodin and 134 
for negative expression of von Willebrand factor, CD31, and smooth muscle cell actin. Cells were 135 
cultured in DMEM containing 4.5 mg/l glucose supplemented with 10% Fetal Calf Serum, 136 
penicillin/streptomycin (100 IU/ml), and l-glutamine and the cultures were maintained at 37 °C in a 137 
95% air/5% CO2 humidified incubator. 138 
2.3 Permeability assay 139 
Podocyte monolayer permeability was determined as previously described [30, 31]. Human 140 
immortalised podocytes (40,000 cells well, 500 μl) were seeded on the top of HTS Transwell inserts 141 
(3 µm pore, 24-well plate) and cultured till confluence was achieved. Cells were washed twice with 142 
PBS supplemented with 1 mM MgCl2 and 1 mM CaCl2 and then pre-treated with vehicle alone or 143 
chlorpheniramine maleate 10 µM for 10 min before exposure to histamine 0.01-1000 nM for 0-8 h. 144 
Fluorescein (FITC)-labeled bovine serum albumin was added to the bottom chambers of the 145 
transwells and medium fluorescence activity in the top chambers was measured at selected time-146 
points with a fluorescence plate reader (excitation: 495 nm, emission: 520 nm; multiple plate reader 147 
Victor X4; PerkinElmer Inc.). Fold-change in expression with respect to the control mean was 148 
calculated for all samples. 149 
2.4 Electron microscopy 150 
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Podocytes pre-treated with vehicle alone or chlorpheniramine maleate 10 µM for 10 min before 151 
exposure to histamine 10 nM or 0.1 nM for 0-8 h were fixed in 4% glutaraldehyde and post-fixed, 152 
after pelletting, in 1% osmium tetroxide and embedded in Epon 812. Ultrathin sections were stained 153 
with uranyl acetate and alkaline bismuth subnitrate and examined under a JEM 1010 electron 154 
microscope (Jeol, Tokyo, Japan) at 20 kV and 50 kV. Morphometrical analysis were performed on 155 
50KV digitized images using ImageJ 1.41 software (http://rsbweb.nih.gov/ij; NIH, USA) in 20 156 
regions of interest (ROI) for each sample. 157 
2.5 RT-PCR 158 
Two µg/µl of total RNA extracted from podocytes by using RevertAid™ First Strand cDNA 159 
Synthesis Kit according to the manufacturer’s instruction, were subjected to RT-PCR as previously 160 
described [26, 32]. The subsequent specific oligonucleotide sequences were used: hH1R forward 5' 161 
CATTCTGGGGGCCTGGTTTCTCT-3' and reverse 5'-CTTGGGGGTTTGGGATGGTGACT-3'; 162 
hH2R forward 5'-CCCGGCTCCGCAACCTGA-3' and reverse 5'-163 
CTGATCCCGGGCGACCTTGA-3'; hH3R forward 5'-CTTCCTGCCCTAGCAGTT-3' and reverse 164 
5'-GCAGAGAACAGCTTCGAGGTT-3' hH4R forward 5'-TGGAAGCGTGATCATCTCAG-3' 165 
and reverse 5'-ATATGGAGCCCAGCAAACAG-3'. PCR amplicons were resolved in an ethidium 166 
bromide-stained agarose gel (2.5%) by electrophoresis. GAPDH gene expression was used as an 167 
internal control. 168 
2.6 Immunocytofluorescence and confocal analysis  169 
Podocytes plated on collagen-coated cover glasses were fixed with 4% paraformaldehyde for 10 170 
minutes at room temperature. H4R was detected using The anti-hH4R (374–390) antibody produced 171 
and validated for detecting both human and rodent H4R in the School of Biological and Biomedical 172 
Sciences, Durham University [33-39]. Sections were incubated overnight with anti-H1R (1.3 173 
µg/ml), anti-H2R (1.3 µg/ml) or anti-H4R (2 µg/ml) receptor subunit at 4°C. Subsequently, for 174 
endoplasmic reticulum (ER) cells were incubated with anti-calnexin (2 µg/ml) followed by 175 
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incubation with the respective Alexa-Conjugated secondary antibodies. The negative control to 176 
exclude non-specific staining by the secondary antibody (where cells were incubated with 177 
secondary antibodies alone) is reported in Supplementary Material Fig. 1. The plasma membrane 178 
was stained using CellMask™ Orange plasma membrane stain according to the manufacturer’s 179 
protocol. Cells were fixed with 4% paraformaldehyde and processed for histamine receptors 180 
staining. Nuclei were stained with Hoescht.All the slides were examined at ×63 magnification using 181 
the SP5 Confocal Laser Scanning Microscope SMD (Leica). A variable number of optical section 182 
images in the z-dimension (z-spacing, 0.42µm) were collected ensuring that images throughout the 183 
3D cellular structure, spanning multiple confocal planes, were fully captured. Maximum projection 184 
of the confocal images were analyzed quantitatively for the extent of colocalization of H1-4Rs with 185 
each of the sub-compartment marker proteins using the ImageJ software package. 186 
2.7 Radioligand binding studies 187 
The saturation binding isotherms were determined by incubating washed podocyte homogenates for 188 
45 min at 25°C with 0–16 nM [3H] mepyramine and assay buffer (50 mM phosphate buffer pH 7.4) 189 
in a total assay volume of 200 μl.The incubation was stopped by rapid dilution with ice-cold assay 190 
buffer. Non-specific binding was determine using unlabelled 10 µM difenhydramine. The bound 191 
radioactivity was separated by filtration through GF/B Glass Fiber Filter Paper that had been treated 192 
with 0.3% polyethyleneimine (PEI). Filters were washed thrice with ice-cold assay buffer and the 193 
radioactivity retained on the filters was measured by liquid scintillation counting. Protein 194 
concentrations were determined according to Bradford methods, using bovine serum albumin as a 195 
standard. 196 
2.8 Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) 197 
The TR-FRET assay was used to evaluate both cAMP and IP1 production by using the LANCE® 198 
Ultra cAMP Detection Kit and the IP-One HTRF® assay kit, respectively, as previously described 199 
[26] and according to their manufacturer's instruction. The energy transfer was measured by the 200 
multiple plate reader Victor X4 (excitation: 620 nm, emission: 665 nm). 201 
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2.9 Quantitative real-time PCR (qRT-PCR) 202 
qRT-PCR was performed on RNA isolated by EuroGOLD Trifast™ according to the 203 
manufacturers’ instructions from podocytes (80% confluence) pretreated with vehicle alone or with 204 
chlorpheniramine maleate at 10 µM and challenged with histamine in the range 3 pM-1000 nM for 205 
0-8 and 24 h. Briefly, first-strand cDNA was produced from 200 ng of total RNA using the High 206 
Capacity cDNA Reverse Transcription Kit. Real-time PCR experiments were performed in 20-μl 207 
reaction mixture containing 5 ng of cDNA template, the sequence-specific oligonucleotide primers 208 
(TJP1 forward: CATCAGATCATTCTGGTCGATCA and reverse: TCCGGAGACTGCCATTGC; 209 
CDH3 forward: CCAGCTTGGGCAACATAGGGTand reverse: 210 
TCAGCTCCCGCTGAGACTACA; VIM forward: GGAACAGCATGTCCAAATCGATand 211 
reverse: CAGCAAACTTGGATTTGTACCATT), and the Power SYBR Green PCR Master Mix. 212 
TATA-binding protein (TBP) mRNA were used to normalise RNA inputs. The relative expression 213 
of mRNA was calculated according to the 2(−ΔCt) method. Fold-change expression with respect to 214 
control was calculated for all samples. 215 
2.10 Immunoblotting 216 
Sixty μg of proteins, extracted by EuroGOLD Trifast™ according to the manufacturers’ 217 
instructions from podocytes (80% confluence) exposed to vehicle alone or pretreated with vehicle 218 
alone or with chlorpheniramine maleate and challenged with histamine in the range 3 pM-1000 nM 219 
for 0-8 and 24 h, were subjected to SDS-PAGE using a 8 % gel. The PVDF membrane was blotted 220 
over-night with goat polyclonal anti-ZO-1, rabbit polyclonal anti-P-cadherin or goat polyclonal 221 
anti-vimentin antibodies (1 μg/ml in PBS) and then re-probed with mouse monoclonal anti-β-actin 222 
antibody (1:5000) to confirm the homogeneity of the proteins loaded. The membranes were 223 
overlaid with Visiglo™ HRP chemiluminescent substrate kit and then exposed to Hyperfilm ECL 224 
film. Densitometric analysis was performed by ImageJ software package. Fold-change expression 225 
with respect to control was calculated for all samples. 226 
2.11 Data analysis and statistical procedures 227 
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Gene and protein expression data are expressed as fold-changes relative to the control (vehicle 228 
alone), which is represented as one-fold. For the permeability assay the mean of the control values 229 
have been calculated and all the individual control values and all the individual test values are 230 
expressed as fold-change relative to the control mean. Results are shown as mean ± SEM from 5 231 
different experiments, and were analysed by Prism 4 software from Graphpad (CA, USA). The test 232 
for normality using the Kolmogorov-Smirnov followed by the one-way ANOVA and the post-hoc 233 
Dunnett’s multiple comparison were performed when there was a variance homogeneity 234 
(permeability assay). In all the other cases, the non-parametric Kruskal-Wallis test was used. For 235 
concentration-response curves a four-parameter logistic equation was applied and the best-fit was 236 
obtained. Radioligand binding data were evaluated by a nonlinear, least-squares curve-fitting 237 
procedure using GraphPad Prism 5. To determine significant differences between means, the 238 
threshold for statistical significance was set to P-values < 0.05. 239 
3 Results 240 
3.1 Histamine compromises SD integrity in human immortalised podocytes 241 
We tested whether the amine influences the transepithelial flow of FITC-albumin in a transwell 242 
assay of monolayer permeability. We found that histamine treatment (0.01-10 nM; 0-8 h) time- and 243 
concentration-dependently and significantly increased fluorescence intenstity in the top chamber 244 
beginning from 6 h (basal level of Fluorescence intensity = 15651 ± 950 FU; P< 0.05) up to 160% 245 
at 8 h (P<0.01; Fig. 1a) with an EC50 of about 0.1 nM (Fig. 1b). Notably, the 10 min pre-treatment 246 
of podocytes with chlorpheniramine maleate was effective in preventing the transepithelial flow of 247 
FITC-albumin, as demonstrated by its ability to partially prevent the effect exerted by histamine 0.1 248 
nM (Fig. 1c).  249 
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 250 
Fig. 1. Junction functional integrity of human immortalized podocyte. Transepithelial albumin 251 
permeability of podocyte monolayer was measured using FITC-BSA. (a) Cells were exposed to 252 
histamine 10 nM from 0 to 8 h. Data, expressed as fold-change over control mean, are means ± 253 
SEM of 5 independent experiments. Statistical analysis was performed by one-way ANOVA and 254 
Dunnett test. *P< 0.05 versus time 0. (b) Cells were exposed to histamine 0 - 1000 nM for 8 h. 255 
Data, expressed as fold-change over control mean, are means ± SEM of four independent 256 
experiments. Statistical analysis was performed by one-way ANOVA and Dunnett test. *P< 0.05 257 
versus concentration 0. (c) Podocytes pretreated for 10 min with vehicle alone or the selective H1R 258 
antagonist, chlorpheniramine maleate 10 μM, were exposed to histamine (0.1 nM) for 8 h. Data, 259 
expressed as fold over control, are means ± S.E.M. of 5 independent experiments. *P< 0.05 versus 260 
vehicle alone and #P< 0.05 versus histamine 0.1 nM. 261 
 262 
 12 
The detrimental effect of H1R activation on SD was strongly validated when the junction integrity 263 
was quantitatively evaluated by electron microscopy. The width of the intercellular space was 264 
narrow and constant throughout the contact area in the control cells (Fig. 2a and b) whereas it was 265 
significantly compromised after histamine exposure for 8 h at 0.1 nM (Fig. 2b), appearing to be 266 
discontinuous and uneven with widening of the paracellular spaces after histamine exposure for 8 h 267 
at 0.1 nM. The pre-treatment with chlorpheniramine maleate was able to ameliorate the histamine 268 
evoked-effects as intercellular spaces appeared narrower, although this was incomplete (Fig. 2a and 269 
b). Chlorphenamine treatment alone did not affect the intercellular contact area. 270 
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 271 
Fig. 2 Chlorpheniramine effect on junction integrity. (a) Representative images of ultrathin 272 
sections from human immortalized podocytes pretreated for 10 min with vehicle alone or the 273 
selective H1R antagonist, chlorpheniramine maleate 10 μM, were exposed to histamine (0.1 nM) for 274 
8 h. The morphological assessment of the junction integrity was carried out in three different 275 
experiments. Sections were examined under a JEM 1010 electron microscope at 20 kV. The insets 276 
show the integrity junctional level detail evaluated at 50 kV. (b) Quantitative analysis of the 277 
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intercellular junction morphology performed on 50KV digitized images. Data, expressed as fold-278 
change over control, are means ± S.E.M. for n = 20 regions of interest (ROI) for each sample. *P< 279 
0.05 versus   vehicle alone and #P< 0.05 versus histamine 0.1 nM. 280 
 281 
3.2 Histamine receptor expression in human immortalised podocytes 282 
In order to further explore the underlying histamine pharmacology, the expression of histamine 283 
receptors in human immortalised podocytes was evaluated at both the gene and protein levels. 284 
Moreover, their functional expression was confirmed by TR-FRET assay evaluating the second 285 
messenger production induced by histamine. As shown in Fig. 3a, RT-PCR analysis revealed single 286 
transcripts corresponding to the predicted size for H1R (403 bp) and H4R (353 bp); H2R (497 bp) 287 
was at the limit of detection. No transcript for H3R (221 bp) was detected. Consistent results were 288 
obtained when protein expression was evaluated by immunocytofluorescence and confocal analysis 289 
(Fig. 3b and c). Indeed, H1R showed a robust staining with a prominent membrane localisation as 290 
demonstrated by its colocalisation with CellMask™ plasma membrane stain (Pearson's coefficient, 291 
r = 0.62; Mander's coefficients threshold for channel 1, red staining, tM1 = 0.38 and Mander's 292 
coefficients threshold for channel 2, green staining, tM2 =0.93); moreover, H1R coimmunolabelling 293 
with calnexin (r = 0.59; tM1 = 0.76 and tM2 = 0.59), suggestive of the presence of a proportion of 294 
H1R on the ER, was also revealed. In comparison, H4R immunolabeling showed a lower 295 
immunopositivity level, predominantly within the cytoplasm where a partial positivity was found in 296 
the ER (r = 0.21, tM1 = 0.30 and tM1 = 0.22 for the colocalization within the membrane and r = 297 
0.29, tM1 = 0.28 and tM2 = 0.33 for the colocalization within the ER; Fig.3b and c). Very modest, 298 
if any, membrane colocalisation was revealed. The staining for H2R was at the limit of the detection 299 
and was not possible to localise it within the membrane. 300 
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 301 
Fig. 3 Histamine receptor expression in human immortalized podocytes. (a) Agarose gels 302 
representative of 5 independent RT-PCR assays for cDNA from human immortalized podocyte. 303 
Single transcripts corresponding to the size predicted for H1R (403 bp), H2R (497 bp), H3R (221 304 
bp), and H4R (353 bp) were detected. The housekeeping gene GAPDH was used as control. (b) 305 
Representative merged immunofluorescence images from 5 independent experiments where cells 306 
were labelled with specific anti-H1 anti-H2, anti-H3, or anti-H4 receptor antibodies (green), 307 
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respectively, calnexin or CellMask™ Plasma Membrane Stains (red). Nuclei were stained with 308 
Hoescht (blue). Detection of yellow colouration, shown by arrows, indicates colocalization.All the 309 
slides were examined at ×63 magnification using the SP5 Confocal Laser Scanning Microscope 310 
SMD (Leica). (c) Scatterplot of red and green pixel intensities of the maximum projection of the 311 
image volume in (b). 312 
 313 
These data suggested the presence of H1R on the surface of human podocytes, therefore a saturation 314 
binding study with the H1R antagonist mepyramine were performed to quantify the receptor levels. 315 
The saturation isotherms revealed a Kd for [3H] mepyramine of 7.02 ± 1.76 nM, indicating the 316 
presence of a single class of high affinity binding sites in podocyte membranes. The binding was 317 
saturable with a Bmax estimate of 376 ± 39 fmol/mg protein (Fig. 4a).  318 
To further confirm our findings, we tested the activation of the histamine receptors evaluating the 319 
levels of cAMP and IP3 second messengers evoked by histamine. As shown in Fig. 4b, podocytes 320 
challenged with histamine (3 pM-10 nM) did not show any changes in cAMP levels, the second 321 
messenger predominantly coupled with Gs (such as H2R) and with Gi (such as H3R and H4R) 322 
receptors. Notably, cells exposed for 1 h to histamine 3 pM-10 nM showed a concentration-323 
dependent decrease in TR-FRET signal, indicating a sigmoidal increase of IP1 (EC50 0.15 ± 0.03 324 
nM). The pre-treatment for 10 min with the selective H1R antagonist chlorpheniramine maleate at 325 
either 1 µM or 10 µM shifted rightwards in a parallel fashion the curve evoked by histamine in a 326 
dose-dependent manner (chlorepheniramine maleate alone did not affecteither cAMP or IP1 327 
production; data not shown). Taken together, these data confirm the functional expression of H1R 328 
on podocyte membrane. 329 
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 330 
Fig. 4 Histamine receptor pharmacological profile in human immortalized podocytes. 331 
Saturation binding curve for [3H]mepyramine binding to podocyte cell membrane homogenates (a). 332 
Data are the mean ± SD of 3 separate cell preparations determined in triplicate. (b) The levels of 333 
IP1, downstream metabolite of IP3, and of cAMP were measured, according to the manufacturer’s 334 
instruction, by IP-One HTRF® assay kit (Cisbio) or by LANCE Ultra cAMP assay (PerkinElmer), 335 
respectively. Human immortalized podocytes were pretreated for 10 min with vehicle alone (black 336 
hexagon, solid line for IP1 and white square solid line for cAMP) or the selective H1R antagonist, 337 
chlorpheniramine maleate 1 μM (white circle, dash line) or 10 μM (white circle, dash-dot line), 338 
were exposed to histamine (3 pM – 10 nM). Results, expressed as TR-FRET signal over the basal 339 
and represented as best-fit concentration-response curve, are the mean ± SEM of 5 independent 340 
experiments run in duplicate. 341 
 342 
3.3 Histamine affects SD protein expression in human immortalized podocyte 343 
The effect evoked by histamine on SD associated proteins ZO-1 and P-cadherin was evaluated at 344 
both gene and protein levels. As shown in Fig. 5a and Fig. 6a, cells challenged with histamine (1 345 
pM–10 nM up to 8 h) showed a time- and concentration-dependent reduction of both TJP1, the gene 346 
encoding for ZO-1, and CDH3, the encoding gene for P-cadherin, with a maximum of approx. 50% 347 
after 6 h. Consistently, similar results with a maximum effect at 8 h were obtained when protein 348 
expression was evaluated (Fig. 5b and c, and Fig. 6b and c).Moreover, histamine evoked a parallel 349 
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induction of the intermediate filament vimentin expression (Figure 5a, b and c and Figure 6a, b and 350 
c), a mesenchymal marker associated with podocyte effacement and detachment [40]. 351 
 352 
Fig. 5 Effect evoked by histamine on ZO-1, P-cadherin and vimentin expression: time-course. 353 
Effect evoked by histamine on ZO-1, P-cadherin and vimentin expression: time-course. Human 354 
immortalized podocytes were treated with histamine (10 nM) from 0 to 8 h. At selected time TJP1, 355 
CDH3 and VIM expression was evaluated by qRT-PCR (a) and ZO-1, P-cadherin and vimentin 356 
protein expression was determined by Western blot analysis (b); results are expressed as mean ± 357 
SEM of five independent experiments; *P< 0.05 versus time 0. Pictures shown are representative of 358 
five independent immunoblotting experiments (c). 359 
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 360 
Fig. 6 Effect evoked by histamine on ZO-1, P-cadherin and vimentin expression: 361 
concentration-response.  Human immortalized podocytes were treated with histamine (0-10 nM) 362 
for 6 or 8 h and processed for TJP1, CDH3 and VIM expression by qPCR (a) and ZO-1, P-cadherin 363 
and vimentin protein expression by Western blot analysis (b), respectively; results are expressed as 364 
mean ± SEM of five independent experiments, *P< 0.05 versus 0 (vehicle alone). Pictures shown 365 
are representative of five immunoblotting independent experiments (c). 366 
 367 
Notably, in our experimental condition, synaptopodin and podocin expression, both markers of 368 
podocyte differentiation, was not affected (Supplementary Material Fig. 2) 369 
When cells were pre-treated with the selective antagonists chlorpheniramine maleate 10 µM, a 370 
parallel rightward shift of the curves evoked by histamine was observed with an increase in EC50 371 
from 0.09 ± 0.03 nM to 7.62 ± 1.44 nM for ZO-1 (Fig. 7a), from 0.13 ± 0.25 nM to 8.57 ± 2.25 nM 372 
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for P-cadherin (Fig. 7b) and from 2.40 ± 1.23 nM to 9.76 ± 3.23 nM for vimentin (Fig. 7c), 373 
respectively. 374 
 375 
Fig. 7 Chlorpheniramine antagonism on ZO-1, P-cadherin and vimentin expression evoked by 376 
histamine.  Human immortalized podocytes pretreated for 10 min with vehicle alone or the 377 
selective H1R antagonist, chlorpheniramine maleate 10 µM were treated with histamine for 8 h and 378 
processed for ZO-1 (a), P-cadherin (b) and vimentin (c) protein expression. Results, represented as 379 
best-fit dose-response curve, are expressed as mean ± SEM of 5 different experiments. 380 
 381 
4 Discussion and Conclusions 382 
This study demonstrates for the first time that histamine, via the H1R, exerts a detrimental direct 383 
effect on SD integrity, which results in an increase in podocyte paracellular permeability. This 384 
effect is underpinned, in part, by the down-regulation of two key proteins vital for the maintenance 385 
of SD integrity, ZO-1 and P-cadherin, with a parallel increase in vimentin expression, the latter 386 
probably promoting an epithelial-mesenchymal transition. Interestingly, our study offers, not only a 387 
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new insight into the effect of histamine on podocyte integrity, but also a clear demonstration of the 388 
involvement of histamine in prolonged permeability leakage. Indeed, the extended kinetics of the 389 
herein observed events (number of hours) are in keeping and strongly support the delayed 390 
mechanism by which histamine increases paracellular permeability involving transcriptional and 391 
transductional events [9]. Similar to what was reported for the endothelial junction [41] and in 392 
keeping with the ability of histamine to alter adhesion at sites between adjacent cells [42], the 393 
results herein suggest that the production of IP3 by histamine interaction with H1R triggers the 394 
activation of a signalling pathway ultimately resulting in an increase in paracellular permeability.  395 
This detrimental effect in the human podocytes is supported by the reduction of the expression of 396 
two vital proteins for the SD integrity, ZO-1 and P-cadherin. Notably, although many in vitro 397 
podocytes cultures showed a cellular dedifferentiation, reflected by loss of processes, and 398 
accompanied by a down-regulation of synaptopodyn, our cells displayed a robust mature phenotype 399 
as indicated by not only synaptopodin and podocin expression (Supplementary Material Fig. 2a and 400 
2c), but also nephrin [43, 44]. Therefore, our in vitro system can be considered a suitable new 401 
model to study SD-associated proteins. Most notably, our data provide evidence to point to human 402 
immortalised podocytes as an interesting new in vitro model to study the histaminergic system in 403 
naïve human cells. Our in vitro cell culture of human immortalised podocytes showed unique 404 
expression pattern for both H1R and HDC enzyme (Supplementary Material Fig. 2a and c), this 405 
suggesting that both the autocrine and paracrine effects of this amine could be studied in this 406 
system. 407 
The unexpected low EC50 (ca. 0.1 nM) herein reported for both ZO-1 and P-cadherin, closely 408 
comparable to the one evoked by histamine when IP3 was measured, could be due, in part, to the 409 
ability of cells to endogenously produce histamine; indeed, our data show that podocytes clearly 410 
express the HDC enzyme (Supplementary Material, Fig. 3 a and b) and that the enzyme is 411 
functionally acting, although with a low rate of histamine production (Supplementary Material, Fig. 412 
3c). The atypical apparent high potency of histamine, may also reflect changes in local histamine 413 
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concentrations over time, H1R membrane expression changes and trafficking during the extended 414 
exposure period (1-8h), or a large portion of spare receptors. Moreover, splice variations [45] and 415 
polymorphisms [46] in human H1R have been observed, and their eventually occurrence in our cells 416 
cannot be ruled out. Although these alternative forms of H1R have not been pharmacologically 417 
characterized thus far, they could be more sensitive to histamine than the wild-type form. The 418 
similar shifts in dose-response curves with the racemic (+/-) chlorpheniramine are consistent with 419 
the range of published pA2 values for native H1R across species and tissues [47-49]. 420 
Notably, the similar EC50s for ZO-1, P-cadherin and IP3 led also to speculate that H1R activation in 421 
human podocytes could initiate different and parallel signaling pathways, which converge in the SD 422 
dysregulation. For instance, it has been reported that the elevation in IP3 triggers the protein kinase 423 
C activation and evokes calcium efflux from the ER thus promoting signals to the cytoskeleton, 424 
ultimately resulting in the increase in permeability [8, 50-52]. However, histamine could affect the 425 
cytoskeleton rearrangement through also a phospholipase C-independent mechanism, evoking the 426 
phosphorylated myosin light chains accumulation through the RhoA/Rho-associated coiled kinase 427 
pathway and activating the mitogen-activated protein kinase p38 [41, 53]. These warrant further 428 
investigation. 429 
Radioligand binding studies demonstrate high affinity [3H]mepyamine binding sites in the podocyte 430 
cells with a mean Kd value comparable to previously published studies for the human H1R [54]. 431 
Consistent with functional data indicating that histamine activates only the canonical H1R-mediated 432 
response (second messenger IP3, evaluated by IP1), and not H2R-, H3R- or H4R-mediated response 433 
(second messenger cAMP), we found that H1R is predominantly localised on the plasma membrane. 434 
Its partial intracellular presence, suggested by co-localization with calnexin, could reflect the 435 
receptor trafficking in the presence of nM histamine concentrations.  436 
Actually, in human podocytes, we clearly detected the H4R receptor at both the gene and protein 437 
level, although no functional evidence of H4R were observed. These data raises the discussion of 438 
the selectivity of H4R antibody [55, 56], however we obtained the same results using different 439 
 23 
commercial H4R antibodies (Supplementary Material, Fig. 4), at least one of which was validated 440 
by H4R-/-mice. The low level of localisation of the H4R at the cell membrane could be a possible 441 
explanation for the lack of the functional evidence. Indeed, we found a predominantly intracellular 442 
localisation accounting for a possible receptor trafficking or for the presence of splice variants of 443 
the H4R. Indeed, the predominant intracellular localisation of H4R splice variants was already 444 
reported by van Rijn and colleagues (2008). However, this speculation needs to be further 445 
investigated and also we could not completely rule out the hypothesis that in this cell type, H4R 446 
might activate alternative second messengers, such as the recruitment of ß-arrestin [57].  447 
Consistent with our results pointing to H1R as the only histamine receptor functionally expressed in 448 
the podocyte membrane, only the pre-treatment with the competitive H1R antagonist, 449 
chlorpheniramine maleate, shifted the curve to the right, while JNJ7777120, a well-known H4R 450 
antagonist prototype, as well as ranitidine, a well-known anti-H2 antihistamine drug, were both 451 
ineffective (Supplementary Material, Fig. 5). All these molecular events, the activation of H1R 452 
leading to the increase in IP3 production and the co-incident reduction in ZO-1 and P-cadherin, may 453 
represent the possible mechanism underlining the detrimental effect of histamine on junction 454 
morphological and functional integrity as suggested by the comparable time- and concentration-455 
response profiles. Notably, although P-cadherin protein expression was already affected after 3 h of 456 
histamine challenge, the permeability leakage was evident only after 6 h, when also ZO-1 457 
expression was reduced. This evidence is in keeping with previous studies showing that modulating 458 
P-cadherin alone is not sufficient for the SD dysregulation [58].  459 
In addition to ZO-1 and P-cadherin down-regulation a parallel increase of vimentin expression was 460 
also observed. Again the concentration-response profile of vimentin induction by histamine was 461 
closely comparable to the one evoked by histamine when IP3 was measured and, again, only the 462 
pre-treatment with chlorpheniramine maleate shifted the curve to the right, thus indicating a pure 463 
H1R-mediated event. The increase of mesenchymal markers, such as vimentin, has been associated 464 
with podocyte effacement, detachment and loss in diabetic nephropathy [40]. Indeed, podocyte 465 
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dedifferentiation and mesenchymal transition could be a potential pathway leading to their 466 
dysfunction, thereby playing a role in the genesis of proteinuria [59].  467 
Histamine was previously demonstrated to alter the link between adherent junction and vimentin in 468 
primary human umbilical vein endothelial cells [50]. Moreover, vimentin was also already reported 469 
to be upregulated by histamine in primary mouse brain organotypic (MBO) cultures [60]. Vimentin 470 
has been also found to be upregulated in podocytes in puromycin aminonucleoside nephrosis [61], a 471 
model characterized by the presence of high levels of histamine in the renal cortex, whose abnormal 472 
metabolism was postulated to be related both as a cause or a consequence of the pathogenenesis 473 
[21].  474 
Interestingly, until now histamine was assumed only to affect the Kf through the H1R and H2R 475 
present on mesangial cells, in keeping with the theory that contraction of these cells leads to a 476 
reduction in the glomerular capillary surface area. We provide for the first time, molecular 477 
pharmacological evidence for a direct effect of histamine on human podocytes, suggestive of a 478 
possible use of antihistamines as add-on therapy to counteract the onset and progression of both 479 
albuminuria and glomeruosclerosis in different renal aetiologies. Previously, this hypothesis was 480 
dismissed by the report that histamine and diphenhydramine had no effect on the alterations in 481 
glomerular ultrafiltration that occurs shortly after administration of anti-glomerular basement 482 
membrane antibody [62] in a model of acute glomerular immune injury in the rat. However, the 483 
authors claimed that it was unlikely that later events would differ greatly regarding a role for 484 
histamine because of the effects of locally injected histamine are immediate and should be evident 485 
early. In our study, we clearly demonstrate that exposure to low concentrations of histamine 486 
promotes important later events on the SD and that these could be prevented by chlorpheniramine. 487 
Taken together these data are suggestive of a combined pathophysiological mechanism of histamine 488 
on Kf, it evokes not only the mesangial cell contraction but also may promote delayed podocyte 489 
detachment, the loss of SD integrity, and subsequent proteinuria and eventual renal damage. 490 
 491 
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Immunocytofluorescence and confocal analysis  
Podocytes plated on collagen-coated cover glasses treated with vehicle alone or histamine 10 nM 
for 0-8 h, were fixed with 4% paraformaldehyde for 10 minutes at room temperature. Sections were 
incubated overnight with goat polyclonal anti-synaptopodin 1.3 µg/ml (N14, sc-21536), rabbit anti-
podocin 2 µg/ml (H130, sc-21009), goat anti-rabbit H4R 2 µg/ml (Y19 sc-33967; Santa Cruz 
Biotechnology Inc., Dallas, TX, USA), or rabbit polyclonal anti-HDC 0.4 µg/ml (HPA038891; 
Sigma–Aldrich St. Louis, MO) at 4°C. After incubation with the respective Alexa-Conjugated 
secondary antibodies the nuclei were stained with Hoescht. All the slides were examined at ×63 
magnification using the SP5 Confocal Laser Scanning Microscope SMD (Leica). A variable 
number of optical section images in the z-dimension (z-spacing, 0.42 µm) were collected ensuring 
that images throughout the 3D cellular structure, spanning multiple confocal planes, were fully 
captured. 
Fluorometric quantification of histamine  
Podocytes seeded at a density of 800.000 cell/ml were pelleted after one hour from medium re-
challenge and the medium was collected. Both pellet and medium were processed accordingly to 
the standard fluorimetric protocol reported in the Histamine Methods & Tools Database 
(https://www.i-med.ac.at/hmtd/) for the quantification of histamine. Histmaine extracted in n-
butanol was reconstituted in aqueous phase using 0.1 N sulphuric acid and n-heptane and assayed 
fluorometrically at 360 nm excitation (Tiligada E, et al. Pharmacol Res 2000).  
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